Meningioma genomics: a therapeutic challenge for clinicians

Meningiomas are amongst the most commonly encountered intracranial tumors. The majority of these tumors arise intracranially, and the remaining incidents occur along the spinal cord. Meningiomas tend to grow gradually, with many tumors arising in inaccessible locations. Such sporadic behavior pos...

Full description

Bibliographic Details
Main Authors: Charbel Moussalem, Elie Massaad, Georges B. Minassian, Louna Ftouni, Shadi Bsat, Mohamad N. El Houshiemy, Safwan Alomari, Rana Sarieddine, Firas Kobeissy, Ibrahim Omeis
Format: Article
Language:English
Published: IMR Press 2021-06-01
Series:Journal of Integrative Neuroscience
Subjects:
Online Access:https://jin.imrpress.com/fileup/1757-448X/PDF/1625014743304-763030558.pdf
_version_ 1811301668290035712
author Charbel Moussalem
Elie Massaad
Georges B. Minassian
Louna Ftouni
Shadi Bsat
Mohamad N. El Houshiemy
Safwan Alomari
Rana Sarieddine
Firas Kobeissy
Ibrahim Omeis
author_facet Charbel Moussalem
Elie Massaad
Georges B. Minassian
Louna Ftouni
Shadi Bsat
Mohamad N. El Houshiemy
Safwan Alomari
Rana Sarieddine
Firas Kobeissy
Ibrahim Omeis
author_sort Charbel Moussalem
collection DOAJ
description Meningiomas are amongst the most commonly encountered intracranial tumors. The majority of these tumors arise intracranially, and the remaining incidents occur along the spinal cord. Meningiomas tend to grow gradually, with many tumors arising in inaccessible locations. Such sporadic behavior poses a therapeutic challenge to clinicians, causing incomplete tumor resections that often lead to recurrence. Therefore, ongoing research seeks to find alternative systematic treatments for meningiomas, with gene-based therapeutics of high interest. Subsequently, genetic studies characterized frequent somatic mutations in NF2, TRAF7, KLF4, AKT1, SMO, and PIK3CA. These genes are communally exhibited in 80% of sporadic meningiomas. In addition, other genes such as the DUSP family, the NR4 family, CMKOR, and FOSL2, have been identified as key players in spinal meningiomas. In this perspective, we aim to investigate current genetic-based studies, with the ongoing research mainly focused on the above NF2, TRAF7, KLF4, AKT1, SMO, and PIK3CA genes and their involved pathways. In addition, this perspective can serve as a potential cornerstone for future genetic analyses of meningioma cases.
first_indexed 2024-04-13T07:12:59Z
format Article
id doaj.art-f52f63b0deaf4eb69b18eea714436d39
institution Directory Open Access Journal
issn 1757-448X
language English
last_indexed 2024-04-13T07:12:59Z
publishDate 2021-06-01
publisher IMR Press
record_format Article
series Journal of Integrative Neuroscience
spelling doaj.art-f52f63b0deaf4eb69b18eea714436d392022-12-22T02:56:50ZengIMR PressJournal of Integrative Neuroscience1757-448X2021-06-0120246346910.31083/j.jin20020491625014743304-763030558Meningioma genomics: a therapeutic challenge for cliniciansCharbel Moussalem0Elie Massaad1Georges B. Minassian2Louna Ftouni3Shadi Bsat4Mohamad N. El Houshiemy5Safwan Alomari6Rana Sarieddine7Firas Kobeissy8Ibrahim Omeis9Division of Neurosurgery, Department of Surgery, American University of Beirut Medical Center, 11-0236 Beirut, LebanonFaculty of Medicine, American University of Beirut Medical Center, 11-0236 Beirut, LebanonDivision of Neurosurgery, Department of Surgery, American University of Beirut Medical Center, 11-0236 Beirut, LebanonFaculty of Medicine, Beirut Arab University, 11072809 Beirut, LebanonDivision of Neurosurgery, Department of Surgery, American University of Beirut Medical Center, 11-0236 Beirut, LebanonDivision of Neurosurgery, Department of Surgery, American University of Beirut Medical Center, 11-0236 Beirut, LebanonDivision of Neurosurgery, Department of Surgery, American University of Beirut Medical Center, 11-0236 Beirut, LebanonDivision of Neurosurgery, Department of Surgery, American University of Beirut Medical Center, 11-0236 Beirut, LebanonDepartment of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, 11-0236 Beirut, LebanonDivision of Neurosurgery, Department of Surgery, American University of Beirut Medical Center, 11-0236 Beirut, LebanonMeningiomas are amongst the most commonly encountered intracranial tumors. The majority of these tumors arise intracranially, and the remaining incidents occur along the spinal cord. Meningiomas tend to grow gradually, with many tumors arising in inaccessible locations. Such sporadic behavior poses a therapeutic challenge to clinicians, causing incomplete tumor resections that often lead to recurrence. Therefore, ongoing research seeks to find alternative systematic treatments for meningiomas, with gene-based therapeutics of high interest. Subsequently, genetic studies characterized frequent somatic mutations in NF2, TRAF7, KLF4, AKT1, SMO, and PIK3CA. These genes are communally exhibited in 80% of sporadic meningiomas. In addition, other genes such as the DUSP family, the NR4 family, CMKOR, and FOSL2, have been identified as key players in spinal meningiomas. In this perspective, we aim to investigate current genetic-based studies, with the ongoing research mainly focused on the above NF2, TRAF7, KLF4, AKT1, SMO, and PIK3CA genes and their involved pathways. In addition, this perspective can serve as a potential cornerstone for future genetic analyses of meningioma cases.https://jin.imrpress.com/fileup/1757-448X/PDF/1625014743304-763030558.pdfgeneticscranial meningiomaspinal meningiomasomatic mutationsgene-targeting therapyneurology
spellingShingle Charbel Moussalem
Elie Massaad
Georges B. Minassian
Louna Ftouni
Shadi Bsat
Mohamad N. El Houshiemy
Safwan Alomari
Rana Sarieddine
Firas Kobeissy
Ibrahim Omeis
Meningioma genomics: a therapeutic challenge for clinicians
Journal of Integrative Neuroscience
genetics
cranial meningioma
spinal meningioma
somatic mutations
gene-targeting therapy
neurology
title Meningioma genomics: a therapeutic challenge for clinicians
title_full Meningioma genomics: a therapeutic challenge for clinicians
title_fullStr Meningioma genomics: a therapeutic challenge for clinicians
title_full_unstemmed Meningioma genomics: a therapeutic challenge for clinicians
title_short Meningioma genomics: a therapeutic challenge for clinicians
title_sort meningioma genomics a therapeutic challenge for clinicians
topic genetics
cranial meningioma
spinal meningioma
somatic mutations
gene-targeting therapy
neurology
url https://jin.imrpress.com/fileup/1757-448X/PDF/1625014743304-763030558.pdf
work_keys_str_mv AT charbelmoussalem meningiomagenomicsatherapeuticchallengeforclinicians
AT eliemassaad meningiomagenomicsatherapeuticchallengeforclinicians
AT georgesbminassian meningiomagenomicsatherapeuticchallengeforclinicians
AT lounaftouni meningiomagenomicsatherapeuticchallengeforclinicians
AT shadibsat meningiomagenomicsatherapeuticchallengeforclinicians
AT mohamadnelhoushiemy meningiomagenomicsatherapeuticchallengeforclinicians
AT safwanalomari meningiomagenomicsatherapeuticchallengeforclinicians
AT ranasarieddine meningiomagenomicsatherapeuticchallengeforclinicians
AT firaskobeissy meningiomagenomicsatherapeuticchallengeforclinicians
AT ibrahimomeis meningiomagenomicsatherapeuticchallengeforclinicians